ASX - By Stock
|
ZLD |
Re:
Ann: ZLD secures additional US$3.25M investment in HOPE SPV
|
|
Way2Go
|
5 |
2.5K |
3 |
23/05/23 |
23/05/23 |
ASX - By Stock
|
5
|
2.5K
|
3
|
|
ASX - By Stock
|
ZLD |
Re:
Ann: Response to ASX Price Query
|
|
Way2Go
|
27 |
11K |
14 |
13/07/22 |
13/07/22 |
ASX - By Stock
|
27
|
11K
|
14
|
|
ASX - By Stock
|
ZLD |
Re:
Ann: Pause in Trading
|
|
Way2Go
|
16 |
7.0K |
3 |
12/07/22 |
12/07/22 |
ASX - By Stock
|
16
|
7.0K
|
3
|
|
ASX - By Stock
|
ZLD |
Re:
General discussion
|
|
Way2Go
|
395 |
163K |
2 |
03/05/22 |
03/05/22 |
ASX - By Stock
|
395
|
163K
|
2
|
|
ASX - By Stock
|
ZLD |
Re:
General discussion
|
|
Way2Go
|
395 |
163K |
3 |
20/04/22 |
20/04/22 |
ASX - By Stock
|
395
|
163K
|
3
|
|
ASX - By Stock
|
ZLD |
Re:
Ann: Results of Meeting
|
|
Way2Go
|
6 |
2.7K |
1 |
19/04/22 |
19/04/22 |
ASX - By Stock
|
6
|
2.7K
|
1
|
|
ASX - By Stock
|
ZLD |
Re:
Ann: EDCDM Technology Licence Agreement Update
|
|
Way2Go
|
15 |
5.2K |
3 |
06/04/22 |
06/04/22 |
ASX - By Stock
|
15
|
5.2K
|
3
|
|
ASX - By Stock
|
ZLD |
Re:
General discussion
|
|
Way2Go
|
395 |
163K |
1 |
04/04/22 |
04/04/22 |
ASX - By Stock
|
395
|
163K
|
1
|
|
ASX - By Stock
|
ZLD |
Re:
Ann: Consolidation/Split - ZLD
|
|
Way2Go
|
21 |
14K |
5 |
31/03/22 |
31/03/22 |
ASX - By Stock
|
21
|
14K
|
5
|
|
ASX - By Stock
|
ZLD |
Re:
Ann: Consolidation/Split - ZLD
|
|
Way2Go
|
21 |
14K |
0 |
30/03/22 |
30/03/22 |
ASX - By Stock
|
21
|
14K
|
0
|
|
ASX - By Stock
|
IHL |
Re:
Ann: Incannex to Issue Loyalty Options to Shareholders
|
|
Way2Go
|
208 |
74K |
1 |
18/03/22 |
18/03/22 |
ASX - By Stock
|
208
|
74K
|
1
|
|
ASX - By Stock
|
ZLD |
Re:
Ann: Consolidation/Split - ZLD
|
|
Way2Go
|
21 |
14K |
8 |
18/03/22 |
18/03/22 |
ASX - By Stock
|
21
|
14K
|
8
|
|
ASX - By Stock
|
ZLD |
Re:
Ann: Ceasing to be a substantial holder
|
|
Way2Go
|
12 |
4.9K |
3 |
08/03/22 |
08/03/22 |
ASX - By Stock
|
12
|
4.9K
|
3
|
|
ASX - By Stock
|
ZLD |
Re:
Ann: Zelira to acquire Health House International Limited
|
|
Way2Go
|
48 |
17K |
3 |
27/02/22 |
27/02/22 |
ASX - By Stock
|
48
|
17K
|
3
|
|
ASX - By Stock
|
ZLD |
Re:
Ann: Zelira expands into NZ via exclusive distribution agreement
|
|
Way2Go
|
63 |
20K |
1 |
18/02/22 |
18/02/22 |
ASX - By Stock
|
63
|
20K
|
1
|
|
ASX - By Stock
|
ZLD |
Re:
Ann: Zelira expands into NZ via exclusive distribution agreement
|
|
Way2Go
|
63 |
20K |
1 |
05/01/22 |
05/01/22 |
ASX - By Stock
|
63
|
20K
|
1
|
|
ASX - By Stock
|
ZLD |
Re:
Ann: ZLDs Phase 1 pain trial published in peer-reviewed journal
|
|
Way2Go
|
19 |
6.6K |
2 |
23/12/21 |
23/12/21 |
ASX - By Stock
|
19
|
6.6K
|
2
|
|
ASX - By Stock
|
ZLD |
Re:
Ann: Zelira expands into NZ via exclusive distribution agreement
|
|
Way2Go
|
63 |
20K |
4 |
20/12/21 |
20/12/21 |
ASX - By Stock
|
63
|
20K
|
4
|
|
ASX - By Stock
|
ZLD |
Re:
Ann: Zelira expands into NZ via exclusive distribution agreement
|
|
Way2Go
|
63 |
20K |
9 |
18/12/21 |
18/12/21 |
ASX - By Stock
|
63
|
20K
|
9
|
|
ASX - By Stock
|
ZLD |
Re:
Ann: ZLD Supports Levins Chronic Pain Trial Ethics Approval
|
|
Way2Go
|
30 |
8.8K |
0 |
09/12/21 |
09/12/21 |
ASX - By Stock
|
30
|
8.8K
|
0
|
|
ASX - By Stock
|
ZLD |
Re:
Ann: ZLD Supports Levins Chronic Pain Trial Ethics Approval
|
|
Way2Go
|
30 |
8.8K |
1 |
07/12/21 |
07/12/21 |
ASX - By Stock
|
30
|
8.8K
|
1
|
|
ASX - By Stock
|
ZLD |
Re:
Ann: Appendix 4C Cash Flow Report
|
|
Way2Go
|
10 |
3.6K |
5 |
29/10/21 |
29/10/21 |
ASX - By Stock
|
10
|
3.6K
|
5
|
|
ASX - By Stock
|
ZLD |
Re:
Ann: Zelira Launches RAF FIVE Acne Treatment Products
|
|
Way2Go
|
46 |
17K |
0 |
25/10/21 |
25/10/21 |
ASX - By Stock
|
46
|
17K
|
0
|
|
ASX - By Stock
|
ZLD |
Re:
Ann: Trading Halt
|
|
Way2Go
|
19 |
6.3K |
0 |
19/10/21 |
19/10/21 |
ASX - By Stock
|
19
|
6.3K
|
0
|
|
ASX - By Stock
|
ZLD |
Re:
Ann: Trading Halt
|
|
Way2Go
|
19 |
6.3K |
1 |
19/10/21 |
19/10/21 |
ASX - By Stock
|
19
|
6.3K
|
1
|
|
ASX - By Stock
|
ZLD |
Re:
Zeliera on proactive
|
|
Way2Go
|
14 |
5.7K |
3 |
03/09/21 |
03/09/21 |
ASX - By Stock
|
14
|
5.7K
|
3
|
|
ASX - By Stock
|
ZLD |
Re:
Dream big with Zelira
|
|
Way2Go
|
1.1K |
428K |
5 |
16/08/21 |
16/08/21 |
ASX - By Stock
|
1.1K
|
428K
|
5
|
|
ASX - By Stock
|
ZLD |
Re:
Ann: June 2021 Quarterly Activities Report
|
|
Way2Go
|
18 |
6.9K |
0 |
31/07/21 |
31/07/21 |
ASX - By Stock
|
18
|
6.9K
|
0
|
|
ASX - By Stock
|
ZLD |
Re:
Dream big with Zelira
|
|
Way2Go
|
1.1K |
428K |
3 |
15/07/21 |
15/07/21 |
ASX - By Stock
|
1.1K
|
428K
|
3
|
|
ASX - By Stock
|
ZLD |
Re:
Dream big with Zelira
|
|
Way2Go
|
1.1K |
428K |
5 |
12/07/21 |
12/07/21 |
ASX - By Stock
|
1.1K
|
428K
|
5
|
|
ASX - By Stock
|
ZLD |
Re:
Ann: Appendix 4C - quarterly
|
|
Way2Go
|
26 |
10K |
3 |
05/05/21 |
05/05/21 |
ASX - By Stock
|
26
|
10K
|
3
|
|
ASX - By Stock
|
ZLD |
Re:
ZLD Chart
|
|
Way2Go
|
847 |
298K |
2 |
13/11/20 |
13/11/20 |
ASX - By Stock
|
847
|
298K
|
2
|
|
ASX - By Stock
|
ZLD |
Re:
Ann: Thorney Becomes a Substantial Strategic Investor in Zelira
|
|
Way2Go
|
101 |
24K |
2 |
23/09/20 |
23/09/20 |
ASX - By Stock
|
101
|
24K
|
2
|
|
ASX - By Stock
|
ZLD |
Re:
Ann: Thorney Becomes a Substantial Strategic Investor in Zelira
|
|
Way2Go
|
101 |
24K |
5 |
23/09/20 |
23/09/20 |
ASX - By Stock
|
101
|
24K
|
5
|
|
ASX - By Stock
|
ZLD |
Re:
Ann: HOPE Range Of Products Launches In Louisiana
|
|
Way2Go
|
73 |
20K |
3 |
20/08/20 |
20/08/20 |
ASX - By Stock
|
73
|
20K
|
3
|
|
ASX - By Stock
|
HXG |
Re:
Ann: Quarterly Activities and Cashflow Report
|
|
Way2Go
|
20 |
5.3K |
1 |
28/07/20 |
28/07/20 |
ASX - By Stock
|
20
|
5.3K
|
1
|
|
ASX - By Stock
|
ZLD |
Re:
Ann: Zelira Enters Deal to Develop Products For Vascular Diseases
|
|
Way2Go
|
88 |
19K |
4 |
22/07/20 |
22/07/20 |
ASX - By Stock
|
88
|
19K
|
4
|
|
ASX - By Stock
|
ZLD |
Re:
Ann: Trading Halt
|
|
Way2Go
|
144 |
37K |
1 |
20/07/20 |
20/07/20 |
ASX - By Stock
|
144
|
37K
|
1
|
|
ASX - By Stock
|
ZLD |
Re:
Ann: Trading Halt
|
|
Way2Go
|
144 |
37K |
3 |
20/07/20 |
20/07/20 |
ASX - By Stock
|
144
|
37K
|
3
|
|
ASX - By Stock
|
ZLD |
Re:
Ann: Zelira Phase 1 Chronic Pain Trial Meets Clinical Endpoints
|
|
Way2Go
|
267 |
47K |
18 |
14/07/20 |
14/07/20 |
ASX - By Stock
|
267
|
47K
|
18
|
|
ASX - By Stock
|
ZLD |
Re:
ZLD Chart
|
|
Way2Go
|
294 |
103K |
2 |
23/06/20 |
23/06/20 |
ASX - By Stock
|
294
|
103K
|
2
|
|
ASX - By Stock
|
ZLD |
Re:
Ann: Notice of General Meeting
|
|
Way2Go
|
37 |
7.0K |
8 |
18/06/20 |
18/06/20 |
ASX - By Stock
|
37
|
7.0K
|
8
|
|
ASX - By Stock
|
ZLD |
Zelira AAN(s) overtime, road to revenue $
|
|
Way2Go
|
17 |
4.7K |
15 |
29/05/20 |
29/05/20 |
ASX - By Stock
|
17
|
4.7K
|
15
|
|
ASX - By Stock
|
ZLD |
Re:
Nice Buy...
|
|
Way2Go
|
59 |
18K |
11 |
21/05/20 |
21/05/20 |
ASX - By Stock
|
59
|
18K
|
11
|
|
ASX - By Stock
|
ZLD |
Re:
News is Starting to Spread in the U.S.
|
|
Way2Go
|
138 |
48K |
4 |
17/04/20 |
17/04/20 |
ASX - By Stock
|
138
|
48K
|
4
|
|
ASX - By Stock
|
ZLD |
Re:
Ann: Insomnia Trial Meets Primary and Secondary Endpoints
|
|
Way2Go
|
51 |
19K |
8 |
09/04/20 |
09/04/20 |
ASX - By Stock
|
51
|
19K
|
8
|
|
ASX - By Stock
|
ZLD |
Re:
can someone explain the dive in sp ?
|
|
Way2Go
|
14 |
8.2K |
2 |
19/02/20 |
19/02/20 |
ASX - By Stock
|
14
|
8.2K
|
2
|
|
ASX - By Stock
|
ZLD |
Re:
Ann: Zelda to merge with US-based Ilera Therapeutics
|
|
Way2Go
|
314 |
142K |
15 |
09/10/19 |
09/10/19 |
ASX - By Stock
|
314
|
142K
|
15
|
|
ASX - By Stock
|
ZLD |
Re:
Ann: US Non-deal Roadshow - Investor Presentation
|
|
Way2Go
|
92 |
49K |
8 |
25/07/19 |
25/07/19 |
ASX - By Stock
|
92
|
49K
|
8
|
|
ASX - By Stock
|
HXG |
Re:
Pick the price of HXG on 13th December 2019 Competition
|
|
Way2Go
|
41 |
11K |
1 |
04/03/19 |
04/03/19 |
ASX - By Stock
|
41
|
11K
|
1
|
|